Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Report
|
The expected Q4 2013 launches of Brintellix and levomilnacipran will occur against a backdrop of a declining market.
Published By Datamonitor
|
25 Apr 2013 |
$3500
|
Report
|
The hepatitis C market will experience a boom as revolutionary interferon-free regimens arrive.
Published By Datamonitor
|
17 Apr 2013 |
$4500
|
Report
|
The IBD market is set to experience considerable change over the next ten years. A number of significant new product launches will reshape the market, with sales for ulcerative colitis forecast to overtake those for Crohn's disease.
Published By Datamonitor
|
22 Mar 2013 |
$4500
|
Report
|
In the wake of Lipitor’s patent expiry, the dyslipidemia market continues to face increasing genericization leading to falling sales in key drug classes.
Published By Datamonitor
|
04 Feb 2013 |
$4500
|
Report
|
New anti-bone loss drugs soon to reach the osteoporosis market - but generic entry will continue to erode its value.
Published By Datamonitor
|
17 Jan 2013 |
$4500
|
Report
|
Renal cell cancer continues to attract drug developers in spite of the crowded nature of the market.
Published By Datamonitor
|
15 Jan 2013 |
$4500
|
Report
|
This report forecasts the pneumococcal vaccine market in the seven major markets (US, Japan, France, Germany, Italy, Spain, and the UK). It segments the market by brand and population groups, considering future changes to national recommendations.
Published By Datamonitor
|
05 Dec 2012 |
$11400
|
Report
|
Analysis of the treatment dynamics in postherpetic neuralgia (PHN). Contains analyses of presentation, diagnosis and treatment rates, and prescribing trends across the seven major markets using Datamonitor’s primary research of 131 physicians.
Published By Datamonitor
|
13 Nov 2012 |
$7600
|
Report
|
Datamonitor provides an overview of and profiles key hemophilia A and B pipeline products launching in the near future in the US and five major EU markets (France, Germany, Italy, Spain, and the UK).
Published By Datamonitor
|
12 Nov 2012 |
$3800
|
Report
|
Overview of non-small cell lung cancer definition and a review of the epidemiologic literature. This report provides an in-depth analysis of patient populations, a 10-year incident forecast, and key patient segments in China.
Published By Datamonitor
|
31 Oct 2012 |
$5700
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.